CoChat
Sign Up
Cited by 20Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Fluoxetine and amitriptyline in elderly depressed patients. A 10-week, double-blind study on course of neurocognitive adverse events and depressive symptoms

De Ronchi, D., Rucci, P., Lodi, M., Ravaglia, G., Forti, P., Volterra, V.·1998·Archives of Gerontology and Geriatrics
DOI 10.1016/s0167-4943(98)80021-6
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/s0167-4943(98)80021-6

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There were no between-group differences for patients in respect of Leeds Sleep Evaluation (LSEQ) scores between amitriptyline (50-100mg) and fluoxetine (20mg).

    “However (De Ronchi et al., 1998) found no between-group differences for patients in respect of Leeds Sleep Evaluation (LSEQ) scores between amitriptyline (50-100mg) and fluoxetine (20mg).”

    From Antidepressants and their effect on sleep (2005) · cites this paper as De Ronchi et al., 1998

  • Improved subjective ratings of sleep have been reported with amitriptyline, clomipramine, imipramine and doxepin.

    “Improved subjective ratings of sleep have been reported with amitriptyline (De Ronchi et al., 1998), clomipramine (Lepine et al., 2000), imipramine (Ware et al., 1989) and doxepin (Hajak et al., 2001).”

    From Antidepressants and their effect on sleep (2005) · cites this paper as De Ronchi et al., 1998

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 49

  1. Altamura, 1989, Efficacy and tolerability of fluoxetine in the elderly: a double blind study versus amitriptyline, Progr. Neuropsychopharmacol., 10, 65
  2. Beasley, 1990, Fluoxetine: relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression, Psyhopharm. Bull., 26, 18
  3. Beasley, 1991, Fluoxetine versus trazodone: efficacy and activating-sedating effects, J. Clin. Psychiatr., 52, 294
  4. Beasley, 1991, High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depression, J. Clin. Psychopharm., 11, 166, 10.1097/00004714-199106000-00004 · DOI
  5. Beasley, 1993, Fluoxetine versus amitriptyline in the treatment of major depression: a multicenter trial, Internat. Clin. Psychopharm., 8, 143, 10.1097/00004850-199300830-00002 · DOI
  6. Bech, 1993, Scales for assessment of diagnosis and severity of mental disorders, Acta Psychiatr. Scand., 372, 1
  7. Blazer, 1989, Anxiety as an outcome symptom of depression in elderly and middle-aged adults, Internat. J. Geriatr. Psychiatry, 4, 273, 10.1002/gps.930040505 · DOI
  8. Brodaty, 1991, Age and depression, J. Affective Disord., 23, 137, 10.1016/0165-0327(91)90026-O · DOI
  9. Brymer, 1992, Fluoxetine in the elderly patients: is there cause of concern?, J. Am. Ger. Soc., 40, 902, 10.1111/j.1532-5415.1992.tb01987.x · DOI
  10. Carman, 1991, A controlled study of mianserin in moderately depressed outpatients, Psychopharm. Bull., 27, 135
  11. Covi, 1984, Primary depression or primary anxiety? A possible psychometric approach to a diagnostic dilemma, Clin. Neuropharm., 7, 501, 10.1097/00002826-198406001-00458 · DOI
  12. Deptula, 1990, Effects of antidepressants on human performance: a review, J. Clin. Psychopharm., 10, 105, 10.1097/00004714-199004000-00005 · DOI
  13. Evans, 1992, Depression in the elderly physically ill: an open study with fluoxetine, J. Clin. Gerontol., 14, 297
  14. Fairweather, 1993, A double blind comparison of the effects of fluoxetine and amitriptyline on cognitive functions in elderly depressed patients, Human Psychopharmacol., 8, 41, 10.1002/hup.470080108 · DOI
  15. Feighner, 1985, Doble-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder, J. Clin. Psychiatr., 46, 20
  16. Feighner, 1988, An overview of fluoxetine in geriatric patients, Br. J. Psychiatr., 153, 105, 10.1192/S0007125000297365 · DOI
  17. Ferrier, 1993, Comparisons of clinical efficacy, Br. J. Psychiatr., 163, 25, 10.1192/S0007125000292337 · DOI
  18. Flint, 1994, Epidemiology and comorbidity of anxiety disorders in the elderly, Am. J. Psychiatr., 151, 640, 10.1176/ajp.151.5.640 · DOI
  19. Folstein, 1975, Mini Mental State: a practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res., 12, 189, 10.1016/0022-3956(75)90026-6 · DOI · Paper page
  20. Gibson, 1981, Brain acetylcholine synthesis declines with senescence, Science, 213, 674, 10.1126/science.7256270 · DOI
  21. Godber, 1983, Depression in old age, Br. Med. J., 287, 758, 10.1136/bmj.287.6394.758 · DOI
  22. Goodnik, 1991, Pharmacokinetics of second generation antidepressant: Fluoxetine, Psychopharmacol. Bull., 27, 503
  23. Gordon, 1981, Elderly depressives: treatment and follow-up, Can. J. Psychiatry, 26, 110, 10.1177/070674378102600208 · DOI
  24. Gram, 1992, Drug interactions and pharamcokinetic risk factors when using antidepressants in the medically ill patients, Clin. Neuropharmacol., 624
  25. Greenwald, 1988, Age and onset in geriatric depression: relationship to clinical variables, J. Affect. Disord., 15, 61, 10.1016/0165-0327(88)90010-9 · DOI
  26. Hamilton, 1960, A rating scale for depression, J. Neurol. Neurosurg. Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
  27. Katz, 1987, The timing, specificity and clinical predictors of tricycling drug effects in depression, Psychol. Med., 17, 297, 10.1017/S0033291700024831 · DOI
  28. Keller, 1995, Anxiety symptom relief in depression treatment outcomes, J. Clin. Psychiatry, 56, 22
  29. La, 1992, Evaluation of efficacy, tolerability and therapeutic profile of fluoxetine versus mianserine in the treatment of depressive disorders in the elderly, Current Therap. Res., 52, 847, 10.1016/S0011-393X(05)80057-8 · DOI
  30. Maier, 1988, Improvement depression severity assessment. Reliability, internal validity and sensitivity to change of three observer depression scales, J. Psychiatr. Res., 22, 3, 10.1016/0022-3956(88)90022-2 · DOI
  31. Meats, 1991, Prognosis of depression in the elderly, Br. J. Psychiatry, 159, 659, 10.1192/bjp.159.5.659 · DOI
  32. Meyers, 1985, Major psychiatric illness in the elderly: empirical study of the experience on a inpatient psychogeriatric unit. Part II. Biological treatment in patients with depressive illness, Int. J. Psychiatry Med., 15, 11, 10.2190/N905-JME3-XWEH-H7V4 · DOI
  33. Millard, 1983, Depression in old age, Br. Med. J., 287, 375, 10.1136/bmj.287.6389.375 · DOI
  34. Mirow, 1991, Cognitive dysfunction associated with fluoxetine, Am. J. Psychiatry, 148, 948, 10.1176/ajp.148.7.948 · DOI
  35. Montgomery, 1979, A new depression rating scale designed to be sensitive to change, Br. J. Psychiatry, 134, 382, 10.1192/bjp.134.4.382 · DOI · Paper page
  36. Montgomery, 1988, The prophylactic efficacy of fluoxetine in unipolar depression, Br. J. Psychiatry, 153, 69, 10.1192/S0007125000297328 · DOI
  37. Murphy, 1983, The prognosis of depression in the old age, Br. J. Psychiatry, 142, 111, 10.1192/bjp.142.2.111 · DOI
  38. NIH CC (Consensus Conference), 1992, Diagnosis and treatment of depression in late life, J. Am. Med. Assoc., 268, 1018, 10.1001/jama.1992.03490080092032 · DOI
  39. Parmelee, 1993, Anxiety and its association with depression among institutionalized elderly, Am. J. Psychiatry, 1, 46, 10.1097/00019442-199300110-00007 · DOI
  40. Parrot, 1980, The Leeds sleep evaluation questionnaire in psychopharmacological investigatons, a review, Psychopharmacology, 71, 173, 10.1007/BF00434408 · DOI
  41. Post, 1972, The management and nature of depressive illness in late life: a follow-through study, Br. J. Psychiatry, 121, 393, 10.1192/bjp.121.4.393 · DOI
  42. Regier, 1988, One month prevalence of mental disorders in the USA based on five epidemiologic cathchment area sites, Arch. Gen. Psychiatry, 45, 977, 10.1001/archpsyc.1988.01800350011002 · DOI · Paper page
  43. Robinson, 1989, The natural history of mental disorder in old age: a long-term study, Br. J. Psychiatry, 154, 783, 10.1192/bjp.154.6.783 · DOI
  44. Salzman, 1993, Pharmacological treatment of depression in the elderly, J. Clin. Psychiatry, 54, 23
  45. Schmidtke, 1988, Untersuchungen zur Rehabilitat und Validitat einer deutschen Version der Montgomery-Asberg Depression Rating Scale (MADRS), Schweiz. Arch. Neurol. Psychiatry, 139, 51
  46. Schone, 1993, A double blind study of paroxetine compared with fluoxetine in geriatric patients with major depression, J. Clin. Psychopharmacol., 13, 34
  47. Small, 1991, Recognition and treatment of depression in the elderly, J. Clin. Psychiatry, 52, 11
  48. Stokes, 1993, Fluoxetine: five years of experience, Clin. Therapeutics, 15, 216
  49. Tollefson, 1993, Analysis of the Hamilton depression rating scale factors from a double blind, placebo controlled trial of fluoxetine in geriatric patients, Int. Clin. Psychopharmacol., 8, 253, 10.1097/00004850-199300840-00008 · DOI

Cited by

Sorted by citations

Metadata

Authors
De Ronchi, D., Rucci, P., Lodi, M., Ravaglia, G., Forti, P., & Volterra, V.
Affiliations
  • University of Bologna (IT)
  • IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
ORCID
Venue
Archives of Gerontology and Geriatrics
Publisher
Elsevier BV
Published
1998-01
Volume
26
Pages
125-140
ISSN
0167-4943 (ISSN-L)
DOI
10.1016/s0167-4943(98)80021-6
OpenAlex
W2011417545
Cited by
20
References
1
Citations by year
2024: 1 · 2022: 1 · 2021: 1 · 2019: 1 · 2015: 1 · 2013: 2 · 2012: 1
FWCI
0.21
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
Archives of Gerontology and Geriatrics (publishedVersion)
Funders
National Institutes of Health
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
fluoxetine, amitriptyline, major depressive disorder, elderly patients, antidepressant efficacy, central nervous system adverse effects, weight gain, dizziness, confusion, sleepiness, sleep, treatment persistence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review